Increased numbers of long-term culture-initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Blood

• Publication date

  1996-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V88.9.3323.BLOODJOURNAL8893323PMID 8896396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.

  1995cited by this paper
• Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution

  1995cited by this paper
• Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs.

  1994cited by this paper
• Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants.

  1994cited by this paper
• Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay.

  1994cited by this paper
• Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.

  1994cited by this paper
• Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells.

  1994cited by this paper
• Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential.

  1993cited by this paper
• Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.

  1993cited by this paper
• Defining a Therapeutic Dose of Peripheral Blood Stem Cells

  1992cited by this paper
• The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons.

  1992cited by this paper
• Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy.

  1992cited by this paper
• The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow.

  1992cited by this paper
• Characterization of primitive hematopoietic cells in normal human peripheral blood.

  1992cited by this paper
• Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse.

  1991cited by this paper
• Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells.

  1991cited by this paper
• Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.

  1991cited by this paper
• Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.

  1991cited by this paper
• Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor

  1990cited by this paper
• Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.

  1990cited by this paper
• An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse.

  1989cited by this paper
• Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia.

  1988cited by this paper
• Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy.

  1988cited by this paper
• Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients.

  1988cited by this paper
• Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia.

  1986cited by this paper
• Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma.

  1986cited by this paper
• The evaluation of limiting dilution assays.

  1982cited by this paper
• Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report.

  1980cited by this paper
• Characterization of an erythroid precursor cell of high proliferative capacity in normal human peripheral blood.

  1977cited by this paper
• Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation.

  1977cited by this paper
• In vitro growth of granulocytic and mononuclear cell colonies from blood of normal individuals.

  1971cited by this paper
• Cells Capable of Colony Formation in the Peripheral Blood of Man

  1971cited by this paper
• Allogeneic marrow engraftment by cross circulation in lethally irradiated dogs.

  1966influential reference

• Cloning of Soluble Human Stem Cell Factor in pET-26b(+) Vector.

  2014cites this paper
• Fusion Protein on Malignant and Normal Hematopoietic Cells Differential Effects of a Stem Cell Factor-Immunoglobulin

  2013cites this paper
• The mechanism of Nov (CCN3) function in haematopoiesis

  2012cites this paper
• Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment

  2011cites this paper
• [Hematopoietic stem cells mobilization: state of the art in 2011 and perspectives].

  2011cites this paper
• Targeting stem cell niches and trafficking for cardiovascular therapy.

  2011cites this paper
• Apoptosis in normal and cancer stem cells.

  2008cites this paper
• Chapter 60 – Collection and Processing of Peripheral Blood Stem Cells and Bone Marrow

  2007cites this paper
• Stem Cell c-KIT and HOXB4 Genes: Critical Roles and Mechanisms in Self-Renewal, Proliferation, and Differentiation

  2006cites this paper
• Design of Recombinant Stem Cell Factor–macrophage Colony Stimulating Factor Fusion Proteins and their Biological Activity In Vitro

  2005cites this paper
• A novel recombinant dual human SCF expressed in and purified from silkworm, Bombyx mori, possesses higher bioactivity than recombinant monomeric human SCF

  2004cites this paper
• Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins.

  2003cites this paper
• Autografting in chronic myeloid leukemia.

  2003cites this paper
• Retroviral transduction efficiency of G-CSF+SCF-mobilized peripheral blood CD34+ cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates.

  2003cites this paper
• Management of infection in children with malignancy.

  2003cites this paper
• Mobilization of peripheral blood progenitor cells with a combination of cyclophosphamide, r-metHuSCF and filgrastim in patients with breast cancer previously treated with chemotherapy

  2003cites this paper
• Paediatric Update Management of infection in children with malignancy

  2003cites this paper
• CHAPTER 53 – Cytokines and cancer

  2003cites this paper
• Isolation and therapeutic potential of human haemopoietic stem cells

  2003cites this paper
• Peripheral Blood Progenitor Cell Collection in Low-Weight Children

  2002influential citation
• Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34+ absolute counts and subsets

  2002cites this paper
• The use of hematopoietic growth factors in the treatment of acute leukemia.

  2002cites this paper
• The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen

  2002cites this paper
• A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation

  2001cites this paper
• Stem Cell Factor: Biology and Relevance to Clinical Practice

  2001cites this paper
• Leukaemogenic potency of WEHI-3B cells grown in vitro or in leukaemic mice

  2001cites this paper
• NOD/SCID repopulating cells but not LTC-IC are enriched in human CD34+ cells expressing the CCR1 chemokine receptor

  2001cites this paper
• NewStrategies in the Treatment of Acute Myelogenous Leukemia: Mobilization and Transplantation of Autologous Peripheral Blood Stem Cells in Adult Patients

  2001cites this paper
• Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia

  2001cites this paper
• Thrombopoietin: Basic Biology and Clinical Effects

  2000cites this paper
• Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy.

  2000cites this paper
• Autologous Stem Cell Transplantation As Post-Remission Therapy in Adult Acute Myelogenous Leukemia: Does Platelet Contamination of Peripheral Blood Mobilized Stem Cell Grafts Influence the Risk of Leukemia Relapse?

  2000cites this paper
• Morphologic, Immunophenotypic and in Vitro Growth Characteristics of Blood and Bone Marrow Associated with Stem Cell Mobilisation in Patients with Lymphoma

  2000cites this paper
• Combination of stem cell factor and granulocyte colony‐stimulating factor mobilizes the highest number of primitive haemopoietic progenitors as shown by pre‐colony‐forming unit (pre‐CFU) assay

  2000cites this paper
• Stem Cell Factor

  2000cites this paper
• Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy

  1999cites this paper
• Chronic myeloid leukemia from basics to bedside

  1999cites this paper
• A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.

  1999cites this paper
• Differential effects of a stem cell factor-immunoglobulin fusion protein on malignant and normal hematopoietic cells.

  1999cites this paper
• The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients

  1999cites this paper
• Optimizing peripheral blood progenitor cell autologous transplantation in multiple myeloma.

  1999cites this paper
• Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone.

  1999cites this paper
• Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia.

  1999cites this paper
• The utilization of cytokines in stem cell mobilization strategies

  1999cites this paper
• Kinetic characteristics of de novo and secondary AML cells influence their response to haemopoietic growth factor (HGF) priming and correlate with clinical outcome.

  1999cites this paper
• Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients

  1999cites this paper
• Prolonged release and c‐kit expression of haemopoietic precursor cells mobilized by stem cell factor and granulocyte colony stimulating factor

  1999cites this paper
• Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF.

  1999cites this paper
• Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial.

  1999cites this paper
• Peripheral blood stem cell transplantation in breast cancer.

  1999cites this paper
• Content of long‐term culture‐initiating cells, clonogenic progenitors and CD34+ cells in apheresis harvests of normal donors for allogeneic transplantation, and in patients with acute myeloid leukaemia or multiple myeloma

  1999cites this paper
• Dose-Intensive Therapy with Autologous Blood Stem Cell or Bone Marrow Transplantation for Treatment of Breast Cancer

  1999cites this paper
• Hemopoietic Stem Cells as Targets for Genetic Manipulation

  1999cites this paper
• Homing of hematopoietic progenitor cells to the bone marrow

  1999cites this paper
• Consensus conference on high-dose therapy with hematopoietic stem cell transplantation in diffuse large-cell lymphoma. Type of cells, optimal mobilization of stem cells--positive and negative selection.

  1998cites this paper
• The therapeutic use of hematopoietic growth factors.

  1998cites this paper
• CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients.

  1998cites this paper
• Processing of hematopoietic stem cell components for transplantation: variations in current practice

  1998cites this paper
• Increased Numbers of Progenitor Cells in the Apheresis Product of Patients Randomised to Receive Increasing Doses of Stem Cell Factor (r-metHuSCF) Administered in Combination with Chemotherapy and a Standard Dose of Filgrastim (r-metHuG-CSF)

  1998cites this paper
• Thrombopoietic factors potentially useful in the treatment of acute leukemia.

  1998cites this paper
• Stem cell factor leads to reduced blood processing during apheresis or the use of whole blood aliquots to support dose-intensive chemotherapy

  1998cites this paper
• Myeloid growth factors in oncology.

  1998cites this paper
• Production and pre-clinical significance of haematopoietic peptide growth factors (HPGF) in human non-seminomatous germ cell tumour cell lines

  1998cites this paper
• Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.

  1998cites this paper
• Stem cell factor and hematopoiesis.

  1997cites this paper
• Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.

  1997cites this paper
• Increased growth promoting but not mast cell degranulation potential of a covalent dimer of c-Kit ligand.

  1997cites this paper
• Mobilization of peripheral blood progenitor cells for allogeneic transplantation.

  1997cites this paper
• Influence of interleukin-3 and other growth factors on alpha4beta1 integrin-mediated adhesion and migration of human hematopoietic progenitor cells.

  1997cites this paper
• In Vivo Effects of Flt3/Flk2 Ligand on Mobilization of Hematopoietic Progenitors in Primates and Potent Synergistic Enhancement With Granulocyte Colony-Stimulating Factor

  1997cites this paper
• In vivo effects of Flt3/Flk2 ligand on mobilization of hematopoietic progenitors in primates and potent synergistic enhancement with granulocyte colony-stimulating factor.

  1997cites this paper
• Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans.

  1997cites this paper
• Stem cell proliferation: Ex vivo and in vivo observations

  1997cites this paper